Search alternatives:
mg decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
mg decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
801
Doxorubicin (A) and Doxorubicinol (B) concentrations in the arterial plasma following the IP administration of 1.5 or 4.5 mg kg-1 Doxorubicin.
Published 2015“…(B) Significance compared to baseline for the 1.5 mg kg-1 dose is denoted by ✝ and 4.5 mg kg-1 by *. α Denotes a decrease (P<0.05) compared to 24 hours. β Denotes difference (P<0.05) between administered doses.…”
-
802
-
803
Blockade of CB<sub>1</sub> receptors does not prevent the anandamide-induced decrease in locomotor activity and rearing.
Published 2016“…<p>Rats were treated with rimonabant (5 mg/kg, ip) and anandamide (10 mg/kg, ip) and horizontal (A) and vertical beam breaks (B) were assessed in the small open field. …”
-
804
Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria
Published 2014“…Unadjusted and multivariable analyses of eGFR association with log-transformed lipid parameters in incremental linear and logistic regression models (with eGFR 90 mL/min/1.73 m<sup>2</sup> as a cut-point) were performed.</p><p>Results</p><p>Mild GFR impairment (eGFR 60–90 mL/min/1.73 m<sup>2</sup>, median urinary ACR 5.25 mg/g) was associated with higher log-transformed Lp(a) values (OR 1.17, p = 0.005) and with clinically atherogenic Lp(a) levels above 30 mg/dL (OR 1.35, p = 0.013) even after full adjustment for demographics, medications, metabolic parameters, and albuminuria. …”
-
805
-
806
-
807
-
808
-
809
-
810
-
811
-
812
-
813
-
814
-
815
-
816
-
817
-
818
-
819
Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro.
Published 2016“…Netrin-1 depletion impedes HCV. Huh7.5 cells were transfected with siRNAs, infected at a MOI of 0.1 24 h after seeding, and trypsinized at day five post-infection before a second siRNA transfection. …”
-
820